Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
Abroad (travel likely)RecruitingPHASE3
Conditions
Atypical Hemolytic Uremic Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, Rio de Janeiro, Brazil
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Ostrava, Poruba, Czechia
Novartis Investigative Site, Nagpur, Maharashtra, India
Novartis Investigative Site, Pune, Maharashtra, India
Novartis Investigative Site, Iruma-gun, Saitama, Japan
Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)
Novartis Investigative Site, Mersin, Yenisehir, Turkey (Türkiye)
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals